Prostrate Cancer Genes Nucleic Acid Amplification Test System

Device Code: 3140

Product Code(s): OYM

Definition: An In Vitro Nucleic Acid Amplification Test That Measures The Concentration Of Prostate Cancer Genes.

Device Classification Information

Device Type ID3140
Device NameProstrate Cancer Genes Nucleic Acid Amplification Test System
Physical StateCapture Oligonucleotides, Magnetic Microparticles, Transcription-based Nucleic Acid Amplification Reagents, Chemiluminescent-labeled Nucleic Acid Probes. Luminometer, Software
Technical MethodUtilizes Nucleic Acid Probes And/or Primers Along With Other Reagents To Detect Prostrate Cancer Genes RNA From Human Specimens.
Target AreaCurrently This Type Of Device Is Only Utilized On Urine Specimens, But Other Specimen Types May Be Possible.
Review PanelImmunology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission TypePMA
FDA Device ClassificationClass 3 Medical Device
Product CodeOYM
GMP ExemptNo
Summary MRIneligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID3140
DeviceProstrate Cancer Genes Nucleic Acid Amplification Test System
Product CodeOYM
FDA Device ClassificationClass 3 Medical Device
TPLC Last Update: 2019-04-02 20:24:29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.